agree and agree although in the low $20's not quite as well/ Looks like a nice V over to my right. If $24 is broken, shorts will not sleep well.
clearly the priest forgot to tell him "sin no more" and thou shalt not steal or tell a lie, or not to covet thy neighbors stock, or kill shareholder value, or not to be greedy...
God please reward the patience of the long suffering shareholders of this forsaken company. Please help us to remove the do-nothing BOD and other hangers-on that are sucking the life and funds out of this company! That's my prayer for the shareholders.
it's shorts + failure of management (mainly Jack and the Bean counter) to create confidence due to insider selling, poor communications, past mistakes, dilution/bad deals with DF. One day soon I hope they will create an opportunity to sell high.
No mention of their 5 rating from basher Z? That's usually why they write these articles. This one appeart to have some real content?
great info, thanks. I follow biotech stocks and hate the lack of timely information on clinical trial enrollment, sales date, etc. Love the transparency and exec management at EXAS. 30MM shares short now. Shorts love scare shareholders with fear and uncertainty. This added info reduces uncertainty.
ARNA has an interesting pipeline and is on sale due to heavy short selling. Some smart biotech firm with drug development talent/expertise can certainly make one, or more of their pipeline products work.
Really, GILD has too much cash, needs to acquire more products. Maybe I should talk to GILD since the ARNA board is not interested.
EXAS is located not that far from Abbott, they are both diagnostic co's and ABT has way too much cash and needs to make an acquisition. Stick it to the shorts!!!
s9 I think JL did a good job of getting ARNA to a certain point, but is not the right person to move the company forward. He's just holding on, soaking the shareholders, trying to learn things that are different from his expertise and that's not good for the shareholders or shareholder value. He should admit he's not the right guy and move on, maybe sit on the BOD if he wants to stay involved.
These desperate short criminals are not going down without a fight. Management will have to be well prepared, are they usually are, on the call. I hate fighting the shorts, they always cause high volatility and shareholder angst along with some trading opportunities. Maybe they will force management to consider all options to cause them max pain including a sale.